The role of Helicobacter pylori in the pathogenesis of gastric malignancies

Oncology Reviews

Volumn 2, Issue 3, 2008, Pages 131-140

  Kim, Woojin ^a   Moss, Steven F ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; MALT lymphoma

Indexed keywords

EID: 79955081634     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-008-0068-y     Document Type: Review

References (81)

1. Danesh J (1999) Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 13:851-856 (Pubitemid 29312768)
2. Atherton JC (2006) The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annual Rev Pathol 1:63-96
3. Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med. 347:1175-1186
4. Kamangar F, Dawsey SM, Blaser MJ et al (2006) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98:1445-1452 (Pubitemid 44605589)
5. Peek RM, Crabtree JE (2006) Helicobacter infection and gastric neoplasia. J Pathol 208:233-248 (Pubitemid 43126116)
6. Correa P, Haenszel W, Cuello C et al (1975) A model for gastric cancer epidemiology. Lancet 12:58-60
7. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 16:1311-1315
8. Parsonnet J, Friedman GD, Vandersteen DP et al (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131
9. Guarner J, Mohar A, Parsonnet J, Halperin D (1993) The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 15:297-301 (Pubitemid 23021211)
10. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. (1993) Lancet 341:1359-1362
11. Nomura A, Stemmermann GN, Chyou PH et al (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136
12. Ekström AM, Held M, Hansson LE et al (2001) Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121:784-791 (Pubitemid 32959388)
13. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789
14. Watanabe T, Tada M, Nagai H (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642-648 (Pubitemid 28397299)
15. Honda S, Fujioka T, Tokieda M (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58:4255-4259 (Pubitemid 28450020)
16. Houghton J, Stoicov C, Nomura S et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 26:1568-1571 (Pubitemid 39564955)
17. Necchi V, Candusso ME, Tava F et al (2007) Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology 132:1009-1023 (Pubitemid 46440875)
18. Basso D, Zambon CF, Letley DP et al (2008) Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms. Gastroenterology Mar 25 [Epub; in press]
19. Amieva MR, El-Omar EM (2008) Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134:306-323 (Pubitemid 350309334)
20. Backert S, Selbach M (2008) Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol Apr 23[Epub; in press]
21. Viala J, Chaput C, Boneca IG et al (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immunology 5:1166-1174 (Pubitemid 39549631)
22. Huang JQ, Zheng GF, Sumanac K et al (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:1636-1644 (Pubitemid 37500427)
23. Galmiche A, Rassow J, Doye A et al (2000) The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 19:6361-6370
24. Moss SF, Sordillo EM, Abdalla AM et al (2001) Increased gastric epithelial cell apoptosis associated with colonization with cagA + Helicobacter pylori strains. Cancer Res 61:1406-1411 (Pubitemid 34292564)
25. Satoh K, Kawata H, Tokumaru K et al (2003) Change in apoptosis in the gastric surface epithelium and glands after eradication of Helicobacter pylori. Dig Liver Dis 35:78-84 (Pubitemid 41490316)
26. Hold GL, Rabkin CS, Chow WH et al (2007) A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132:905-912 (Pubitemid 46440859)
27. El-Omar EM, Rabkin CS, Gammon MD (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193-1201 (Pubitemid 36531795)
28. El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402 (Pubitemid 30164342)
29. Staszewski J (1972) Migrant studies in alimentary tract cancer. Recent Results Cancer Res 39:85-97
30. Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H (2003) Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 13:162-168 (Pubitemid 44143816)
31. Shikata K, Kiyohara Y, Kubo M et al (2006) A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 119:196-201
32. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1-241
33. Ford AC, Delaney BC, Forman D, Moayyedi P (2006) Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev Apr 19:CD003840
34. Fock KM, Talley N, Moayyedi P et al (2008) Asia-Pacific Gastric Cancer Consensus Conference Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23:351-365 (Pubitemid 351342074)
35. Leung WK, Wu MS, Kakugawa Y et al (2008) Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9:279-287 (Pubitemid 351722947)
36. Malfertheiner P, Megraud F, O'Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56:772-781 (Pubitemid 46854190)
37. Correa P, Fontham ET, Bravo JC et al (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 92:1881-1888 (Pubitemid 32036918)
38. Mera R, Fontham ET, Bravo LE et al (2005) Long term follow up of patients treated for Helicobacter pylori infection. Gut 54:1536-1540 (Pubitemid 41531767)
39. Fuccio L, Zagari RM, Minardi ME, Bazzoli F (2007) Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 25:133-141 (Pubitemid 46046370)
40. Wong BC, Lam SK, Wong WM et al (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291:187-194 (Pubitemid 38082812)
41. Dixon MF (2001) Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 49:2-4 (Pubitemid 32601868)
42. Take S, Mizuno M, Ishiki K et al (2007) Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 42[Suppl17]:21-27 (Pubitemid 46140359)
43. Lee CW, Rickman B, Rogers AB et al (2008) Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 68:3540-3548
44. Romero-Gallo J, Harris EJ, Krishna U et al (2008) Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 88:328-336 (Pubitemid 351311284)
45. Tamura G (2002) Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol 17:323-329 (Pubitemid 34116433)
46. Leung WK, Man EP, Yu J et al (2006) Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 12:3216-3221 (Pubitemid 43837372)
47. Perri F, Cotugno R, Piepoli A et al (2007) Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori- infected patients and effect of eradication. Am J Gastroenterol 102:1361-1371
48. Kang JM, Kim N, Yoo JY et al (2008) The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter 13:146-156 (Pubitemid 351347663)
49. Mukoubayashi C, Yanaoka K, Ohata H et al (2007) Serum pepsinogen and gastric cancer screening. Intern Med 46:261-266 (Pubitemid 46488392)
50. Plummer M, Vivas J, Lopez G et al (2007) Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst 99:137-146
51. You WC, Brown LM, Zhang L et al (2006) Randomized doubleblind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 98:974-983 (Pubitemid 44288162)
52. Leung WK, Ng EK, Chan FK et al (2006) Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. Clin Cancer Res 12:4766-4772 (Pubitemid 44297831)
53. Yang HB, Cheng HC, Sheu BS et al (2007) Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther 25:455-461
54. Meimarakis G, Winter H, Assmann I et al (2006) Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 7:211-222 (Pubitemid 43286451)
55. Uemura N, Mukai T, Okamoto S et al (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639-642 (Pubitemid 27342688)
56. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary Bcell gastric lymphoma. Lancet 338:1175-1176
57. Harris NL, Jaffe ES, Diebold J et al (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, Hematol J 1:53-66
58. Morgner A, Schmelz R, Thiede C et al (2007) Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastro 13:3554-3566 (Pubitemid 47162262)
59. Parsonnet J, Hansen S, Rodriguez L et al (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271 (Pubitemid 24129959)
60. Eck M, Schmausser B, Haas R et al (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112:1482-1486 (Pubitemid 27181371)
61. Zhu Y, Wang C, Huang J et al (2007) The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis. Cell Microbiol 9:952-961 (Pubitemid 46394906)
62. El-Omar EM, Ng MT, Hold GL (2008) Polymorphisms in tolllike receptor genes and risk of cancer. Oncogene 27:244-252
63. Cheng TY, Lin JT, Chen LT (2006) Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosaassociated lymphoid tissue lymphoma. J Clin Oncol 24:3483-3489
64. Wotherspoon AC, Doglioni C, Diss TC (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577 (Pubitemid 23259233)
65. Steinbach G, Ford R, Glober G et al (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131:88-95 (Pubitemid 29340559)
66. Kim JS, Chung SJ, Choi YS (2007) Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Brit J Can 96: 1324-1328 (Pubitemid 46685779)
67. Hong SS, Jung HY, Choi KD et al (2006) A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter 11:569-573 (Pubitemid 44674142)
68. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, EGILS (European Gastro-Intestinal Lymphoma Study) Group (2007) Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56:1685-1687 (Pubitemid 350206294)
69. Wündisch T, Thiede C, Morgner A (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23:8018-8024 (Pubitemid 46657403)
70. Lévy M, Hammel P, Lamarque D (1997) Endoscopic ultrasonography for the initial staging and follow-up in patients with lowgrade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 46:328-333 (Pubitemid 27459270)
71. El-Zahabi LM, Jamali FR, El-Hajj II et al (2007) The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc 65:89-96 (Pubitemid 44932160)
72. Montalban C, Santon A, Boixeda D, Bellas C (2001) Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 49:584-587 (Pubitemid 32896991)
73. Delchier JC, Lamarque D, Levy M (2001) Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am J Gastroenterol 96:2324-2328 (Pubitemid 32769190)
74. Raderer M, Streubel B, Wöhrer S et al (2006) Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 55:616-618
75. Du MQ (2007) MALT Lymphoma: Recent advances in aetiology and molecular genetics. J Clin Exp Hematopathol 47:31-42
76. Nakamura M, Murayama SY, Serizawa H et al (2007) Candidatus Helicobacter heilmannii from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect Immun 75:1214-1222 (Pubitemid 46385812)
77. Nishikawa K, Nakamura M, Takahashi S (2007) Increased apoptosis and angiogenesis in gastric low-grade mucosa-associated lymphoid tissue-type lymphoma by Helicobacter heilmannii infection in C57/BL6 mice. FEMS Immunol Med Microbiol 50:268-272 (Pubitemid 46918651)
78. Nakamura S, Matsumoto T, Ye H et al (2006). Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 107:2770-2778 (Pubitemid 44937029)
79. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A et al (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39-40 (Pubitemid 32056501)
80. Nakamura T, Seto M, Tajika M et al (2008) Clinical Features and Prognosis of Gastric MALT Lymphoma With Special Reference to Responsiveness to H. pylori Eradication and API2-MALT1 Status. Am J Gastroenterol 103:62-70
81. Wilson KT, Crabtree JE (2007) Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133:288-308 (Pubitemid 47031142)